The mitotic arrest deficient protein MAD2B interacts with the clathrin light chain A during mitosis by Medendorp, K. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
OPEN 3  ACCESS Freely available online PIPS one
The Mitotic Arrest Deficient Protein MAD2B Interacts 
with the Clathrin Light Chain A during Mitosis
Klaas M ed end o rp 1, Lilian V reede1, Jan J. M . van G roningen1, Lisette H etterschijt1, Linda Brugm ans1, 
Patrick A. M . Jansen2, W ilhelm ina H. van den H urk1, D iederik  R. H. de Bruijn1, Ad Geurts van Kessel1*
1 Department o f Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands, 2 Department 
o f Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
Abstract
Background: Although the mitotic arrest deficient protein MAD2B (MAD2L2) is thought to inhibit the anaphase promoting 
complex (APC) by binding to CDC20 and/or CDH1 (FZR1), its exact role in cell cycle control still remains to be established.
Methodology/Principal Findings: Using a yeast two-hybrid interaction trap we identified the human clathrin light chain A 
(CLTA) as a novel MAD2B binding protein. A direct interaction was established in mammalian cells via GST pull-down and 
endogenous co-immunoprecipitation during the G2/M phase of the cell cycle. Through subsequent confocal laser scanning 
microscopy we found that MAD2B and CLTA co-localize at the mitotic spindle. Clathrin forms a trimeric structure, i.e., the 
clathrin triskelion, consisting of three heavy chains (CLTC), each with an associated light chain. This clathrin structure has 
previously been shown to be required for the function of the mitotic spindle through stabilization of kinetochore fibers. Upon 
siRNA-mediated MAD2B depletion, we found that CLTA was no longer concentrated at the mitotic spindle but, instead, diffusely 
distributed throughout the cell. In addition, we found a marked increase in the percentage of misaligned chromosomes.
Conclusions/Significance: Previously, we identified MAD2B as an interactor of the renal cell carcinoma (RCC)-associated 
protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs 
results in an impairment of this interaction and a concomitant failure to shuttle MAD2B to the nucleus. Our current data 
show that MAD2B interacts with CLTA during the G2/M phase of the cell cycle and that depletion of MAD2B leads to a 
marked increase in the percentage of misaligned chromosomes and a redistribution of CLTA during mitosis.
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Introduction
The mitotic arrest deficient protein MAD2B (MAD2L2) is a 
member of a MAD family of proteins and shows 48% similarity to 
MAD2 (MAD2L1) [1,2]. Both MAD2 and MAD2B can bind to the 
anaphase promoting complex or cyclosome (APC/C), which is a 
downstream target of the mitotic spindle checkpoint. APC/C is 
activated by CDC20 and/or CDH1 (FZR1), whereas MAD2 and 
MAD2B can act as APC/C inhibitors by binding to CDC20 and/or 
CDH1, respectively [3,4]. More recently, it was found that during 
mitosis clathrin is localized to kinetochore fibres of the spindle [5]. 
Clathrin is composed of heavy (CLTC) and light (CLTA/CLTB) 
chains, respectively, and direct binding of clathrin to the 
kinetochore fibres is thought to be mediated by the heavy chain, 
since in the absence of CLTC, clathrin light chains are no longer 
recruited to the spindle [5]. Once bound to the mitotic spindle 
apparatus, clathrin stabilizes mitotic microtubules by forming a 
trimeric structure, i.e., the clathrin triskelion [6]. RNAi-mediated 
knock down of CLTC leads to kinetochore fiber de-stabilization and 
concomitant defective congression of chromosomes to the meta­
phase plate and persistent activation of the spindle checkpoint. 
Normally, MAD2 is localized to kinetochores in early prometaphase
and becomes diffusely distributed in metaphase. Since in CLTC 
depleted cells MAD2 was found to be located at the kinetochores of 
both misaligned chromosomes and chromosomes at the metaphase 
plate, it was concluded that the persistent spindle checkpoint 
activation may be mediated by MAD2 signalling [5]. Together, 
these observations suggest that clathrin may act as an integral 
component of the mitotic spindle apparatus and that its abrogation 
may lead to chromosomal instability and, ultimately, cancer [7-9]. 
Interestingly, fusions of CLTC with the anaplastic lymphoma kinase 
(ALK) have been encountered in inflammatory myofibroblastic 
tumors and anaplastic large-cell lymphomas [10], whereas fusions 
with the transcription factor TFE3 have been encountered in renal 
cell carcinomas (RCC) [11,12]. These fusions are expected to 
disrupt clathrin trimerization, thereby impairing its function during 
mitosis [5]. Previously, we found that in RCCs carrying a recurrent 
t(X;1)(p11;q21) chromosome translocation TFE3 is fused to a novel 
protein, PRCC [13,14]. Subsequently, we found that PRCC can 
interact with MAD2B and, by doing so, mediate its shuttling to the 
nucleus [15]. The PRCCTFE3 fusion protein, however, has lost this 
capacity in spite of the fact that the PRCC interaction domain is 
retained in the fusion product. Based on these results, we previously 
hypothesized that the putative role of MAD2B in cell cycle control
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Figure 1. MAD2B and C LTA  interact physically. (A) Schematic representation of the CLTA (deletion) constructs (numbers correspond to amino 
acid positions) and corresponding interactions with MAD2B measured as OD42O/OD6OO ratios using a liquid b-galactosidase assay. (B) HA-MAD2B 
protein was probed for interaction with either GST or GST-CLTA. Subsequent western blot analysis was performed using an anti-HA tag antibody. (C) 
U2OS cells were transiently transfected with HA-MAD2B and FLAG-CLTA. Immunoprecipitations (IP) were performed with a control rabbit antibody 
(IgG) and an anti-MAD2B antibody as indicated. Western blot analysis was performed using an anti-FLAG antibody. (D) U2OS cells were synchronized 
by a double thymidine block (see Materials and methods) and subsequently harvested at different time intervals after release from this cell cycle 
block. Immunoprecipitations were performed on cell lysates from unsynchronized cells and from cells at t = 0 and t = 12 after release. Endogenous 
proteins were precipitated with an anti-CLTA and a control mouse antibody (IgG) as indicated. Western blot analysis was performed using anti-CLTA 
and anti-MAD2B antibodies. 
doi:10.1371/journal.pone.0015128.g001
may be abrogated through PRCCTFE3 expression in t(X;1) 
(p11;q21)-positive RCCs [15]. To further assess this role, we 
performed a yeast two-hybrid interaction screen with MAD2B as a 
bait. By doing so, we identified the clathrin light chain CLTA as a 
novel bona fide interactor.
Results
Identification of CLTA as a MAD2B binding protein
In order to further assess the role of MAD2B in cell cycle control, 
we set out to identify binding proteins using a yeast two-hybrid 
interaction trap (see Materials and methods). By employing the full 
coding sequence of MAD2B as bait and a human testis cDNA library 
as prey, we recovered 92 colonies that grew on fully selective SD 
medium. Of these colonies, 87 turned blue in a LacZ filter lift assay 
and 69 were selected for further analysis. The corresponding 
plasmids were recovered and re-introduced into the same yeast cells 
and, subsequently, these cells were plated in fully selective SD
medium and re-screened for b-galactosidase activity. These 
combined assays yielded six independent plasmids, all encompassing 
coding sequences for the clathrin light chain A (CLTA) protein. 
Among these six clones, five clones contained full-length CLTA 
coding sequences and one clone truncated sequences coding for its 
C-terminal 100 amino acids. Co-transfection of these prey clones 
with standard control plasmids encoding lamin-B and p53 turned 
out to be negative, thereby validating the yeast two-hybrid 
interactions observed. In order to refine the identification of a 
specific domain of CLTA required for interacting with MAD2B, a 
series of deletion constructs was generated lacking consecutive 
stretches of 50 amino acids at either the C- or N-terminal regions of 
the coding sequence (Fig. 1A). The resulting CLTA (deletion) 
constructs were co-transfected with full-length MAD2B into yeast 
cells and tested for their ability to grow on fully selective SD medium 
and for b-galactosidase activity. The data obtained indicate that the 
C-terminal region (containing amino acids 151-218) is required for 
the MAD2B-CLTA interaction, since all C-terminal deletions of the
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CLTA protein resulted in a complete abrogation of yeast growth (not 
shown) and b-galactosidase activity (Fig. 1A). In addition, the central 
domain of CLTA appears to be essential, but not sufficient, for 
binding to the MAD2B protein. These observations are completely 
in line with our initial yeast two-hybrid screening data. A reduction 
of the critical interaction domain within the MAD2B protein could 
not be attained, since all deletions, including N-terminal and C- 
terminal deletions (see materials and methods), resulted in a 
complete abolition of the MAD2B-CLTA interaction (data not 
shown).
MAD2B and CLTA interact physically
To investigate whether the MAD2B protein physically interacts 
with CLTA, we performed a glutathione S-transferase (GST) pull­
down assay. To this end, full length GST-CLTA fusion protein was 
produced in E. coli cells, and full-length HA-tagged MAD2B (HA- 
MAD2B) was expressed in U2OS cells. After pull down of the GST- 
CLTA fusion protein, and GST as a control, the samples were 
analyzed by western blotting using an anti-HA antibody. By doing 
so, we found that the MAD2B protein (expected size, 28-29 kDa)
[3] was pulled down with the GST-CLTA fusion protein, but not 
with GST alone (Fig. 1B), thus supporting a physical in vitro 
interaction between MAD2B and CLTA. To further confirm this 
interaction in vivo, U2OS cells were transiently transfected with HA- 
MAD2B and FLAG-tagged CLTA (FLAG-CLTA) expression 
constructs. Subsequently, immunoprecipitations were performed 
on the double transfectants using an anti-MAD2B antibody to 
precipitate MAD2B and/or HA-MAD2B. After western blotting 
using an anti-FLAG antibody, the FLAG-CLTA protein could 
readily be observed in the input and the anti-MAD2B immuno- 
precipitate, but not in the mock (IgG) immunoprecipitate (Fig. 1C), 
thus confirming the in vivo interaction between exogenous MAD2B 
and CLTA in mammalian cells. Subsequently, the endogenous 
interaction between MAD2B and CLTA was assessed. To this end, 
U2OS cells were synchronized (double thymidine block, see 
Materials and methods) and subsequently harvested at different 
time points after release from this cell cycle block. Concomitant 
FACS analyses (Fig. S1) revealed that the majority of unsynchro­
nized cells was in the G0 and/or G1 phase ofthe cell cycle and that 
before release from the cell cycle block (t = 0) the majority of cells 
was in the S phase of the cell cycle, as expected. At 12 hours after 
release from the cell cycle block (t = 12) the majority of cells was in 
the G2 and/or M phase. After protein extraction from these 
respective samples, immunoprecipitations were carried out using an 
anti-CLTA antibody. Subsequent western blot analysis with an anti- 
MAD2B antibody readily revealed MAD2B protein in the CLTA 
immunoprecipitate at t=  12, but not in the other immunoprecip- 
itation samples (i.e., unsynchronized and t = 0; Fig. 1D), thereby 
confirming an endogenous interaction of these two proteins, 
primarily during the G2 and/or M phase of the cell cycle.
Since CLTA is known to form a complex with the clathrin 
heavy chain (CLTC) during mitosis, i.e., the triskelion, we 
investigated whether endogenous MAD2B can bind to this 
complex. To this end, U2OS cells were grown in the presence 
of 35S labeled methionine and, subsequently, whole cell lysates 
were prepared and used for immunoprecipitation with an anti- 
MAD2B, an anti-CLTA and a control IgG antibody. By doing so, 
we observed a strong band of —190 kDa (CLTC; Fig. S2A) after 
immunoprecipitation with the anti-CLTA antibody, as expected 
[9,16]. This same band was also observed after immunoprecip- 
itation with the anti-MAD2B antibody, but not with the control 
IgG antibody, thus indicating that endogenous MAD2B can 
indeed bind to the CLTA-CLTC complex, presumably in its 
triskelion configuration.
MAD2B and CLTA co-localize at the mitotic spindle
In order to further assess the observed interaction between 
MAD2B and CLTA in mammalian cells, expression constructs 
carrying full-length coding sequences of mRFP-tagged MAD2B and 
GFP-tagged CLTA were transiently transfected into U2OS cells. 
After confocal laser scanning microscopy, we found that MAD2B 
exhibited a diffuse staining pattern in both the cytoplasm and the 
nucleus (Fig. 2, upper panels), as expected [15,17]. Also as expected 
[5,18], CLTA showed a punctate membranous/cytoplasmic 
distribution with an accumulation at the Golgi apparatus (Fig. 2, 
upper panels). CLTA was not observed within the nucleus during 
interphase. Accordingly, CLTA and MAD2B failed to show any 
overt sub-cellular co-localization during interphase. In order to 
assess the sub-cellular localization of both proteins during mitosis, 
U2OS cells were again synchronized with a double thymidine block 
(see above) and fixed at different time intervals after release. By 
doing so, we found that during mitosis CLTA was located at the 
mitotic spindle co-localizing with a-tubulin (Fig. S3). MAD2B 
exhibited a very similar localization at the mitotic spindle, and the 
overlay of both corresponding fluorescent signals revealed a perfect 
co-localization (Fig. 2, lower panels, yellow staining), thus fully 
corroborating the above protein-protein interaction data.
Cellular re-distribution of CLTA and chromosomal 
misalignment after MAD2B knockdown
Having established that MAD2B and CLTA interact and co- 
localize at the spindle during mitosis, we next questioned what the 
effect on the sub-cellular localization ofthese proteins would be after 
depletion. To this end, we generated a stable MAD2B siRNA- 
inducible HEK293 cell line (see Materials and methods) in which, 
after 4 days of tetracyclin induction, the amount of MAD2B protein 
was reduced to 2% (Fig. 3A). Both non-depleted and MAD2B- 
depleted cells were fixed, incubated with an anti-CLTA antibody 
and analyzed by immunofluorescence. In accordance with the above 
exogenous expression data, we found that in the non-depleted cells 
endogenous CLTA also exhibited a punctuated cytoplasmic staining 
pattern with a perinuclear (Golgi) accumulation during interphase 
(Fig. 3B, upper panels). In MAD2B-depleted cells a similar pattern 
was observed (not shown). During mitosis endogenous CLTA was, 
again in accordance with the above exogenous expression data, 
localized at the mitotic spindle (Fig. 3B, middle panels). In contrast, 
however, we found that in the MAD2B-depleted cells endogenous 
CLTA no longer localized at the mitotic spindle but, instead, was re­
distributed diffusely throughout the cell (Fig. 3B, lower panels). The 
endogenous localization of CLTC was unaffected in these cells (Fig. 
S2B). In order to assess the effect of MAD2B depletion on an orderly 
mitotic progression, we systematically analyzed mitotic figures from 
HEK293/T-REx MAD2B knock down cells (+MAD2B siRNA) 
using live cell imaging and compared these with those similarly 
obtained from wild-type HEK293/T-REx cells (- MAD2B siRNA). 
By doing so, we observed a significant overall increase (34.65% 
versus 11.65%, T-test, p = 0.030) in misaligned chromosomes in the 
knock down cells (Table S1), including centrophilic chromosomes, 
anaphase bridges and lagging chromosomes (Fig. 4; indicated by 
arrows in left, middle and right panels, respectively). A marked 
increase in chromosome aberrations after siRNA-mediated knock 
down of MAD2B has also been reported by Cheung et al. [19] in 
nasopharyngeal carcinoma cells in response to DNA damage, thus 
corroborating the results obtained here.
In order to assess whether exogenous expression of PRCCTFE3, 
which fails to shuttle MAD2B to the nucleus [15], has a similar effect 
on mitotic progression as siRNA-mediated MAD2B depletion, we 
systematically analyzed mitotic figures from induced HEK293/T- 
REx PRCCTFE3 cells (+PRCCTFE3) and compared these with
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DAPI CLTA MAD2B Merge
Figure 2. MAD2B and C LT A  co-localize at the mitotic spindle. Cells were transiently transfected with CLTA-GFP (green) and MAD2B-mRFP 
(red) constructs. DAPI staining (blue) marks the position of the nuclei and chromosomes. Yellow staining in the overlay indicates co-localization of 
MAD2B and CLTA. The upper two panels show cells in interphase, the lower two panels show cells in mitosis. 
doi:10.1371/journal.pone.0015128.g002
those similarly obtained from un-induced HEK293/T-REx 
PRCCTFE3 cells (- PRCCTFE3). Also here, a significant overall 
increase (78.22% versus 30.10%, T-test, p = 0.024) in misaligned 
chromosomes was observed in the induced versus un-induced cells 
including, again, centrophilic chromosomes, anaphase bridges and 
lagging chromosomes (Fig. 5; Table S2).
Discussion
Using a yeast two-hybrid-based interaction trap with MAD2B as 
a bait we identified the human clathrin light chain A (CLTA) as a 
novel bona fide interactor. The interaction was subsequently 
confirmed in mammalian cells using both in vitro and in vivo assays, 
and the interaction interface could be narrowed down to two 
domains, i.e., a C-terminal and a central domain. Previously, the 
CLTA C-terminal domain was found to function as a calmodulin- 
binding domain, whereas the central domain was found to function 
as a clathrin heavy chain (CLTC) binding domain [9]. This CLTC 
binding domain, in turn, was found to be essential for the formation 
of the clathrin trimeric structure, i.e., the clathrin triskelion [6]. It 
has been reported that the C-terminus of CLTA can also interact 
with the trimerization domain of the clathrin triskelion structure. 
We found that endogenous CLTC co-immunoprcipitates with 
MAD2B, suggesting that MAD2B may bind to clathrin in its 
triskelion conformation. Since our results additionally showed that 
full-length MAD2B protein is required for maintaining the
interaction with CLTA, this interaction appears to be dependent 
on a proper folding of the protein and/or a proper exposure of its 
interaction interface(s) such as the HORMA domain [2,20]. 
Additional evidence suggests that MAD2B may form multimeric 
configurations, a feature that has been extensively documented for 
the various protein-protein interactions exhibited by its closely 
related homolog MAD2 [21,22]. Clathrin is similarly known to 
form multimeric lattices during clathrin-mediated membrane 
trafficking (i.e., coated vesicles) in interphase cells [23]. More 
recently it was discovered that clathrin may also play an important 
role in the mitotic spindle checkpoint [5]. Through gene trapping of 
nuclear proteins [24] and mass spectrometry of purified mitotic 
spindles [25] it has been established that clathrin is an integral 
component of the mitotic spindle. Using GFP-tagged clathrin light
[18] and heavy [5] chains it was found that both subunits are 
recruited to microtubules as these invade the nuclear lamina during 
early prophase. Subsequently, clathrin remains associated with the 
spindle microtubules throughout chromosome congression, meta­
phase and chromosome segregation during anaphase. Only during 
telophase, clathrin is dissociated, followed by a re-establishment of 
clathrin proteins in the Golgi apparatus. Using immunofluorescence 
(electron) microscopy, it was found that clathrin is intimately 
associated with kinetochore fibers, bundles of microtubules that 
connect the spindle pole to the kinetochores of chromosomes [5]. 
When CLTC was depleted from the cells a number of mitotic 
defects was encountered, including misaligned chromosomes, such
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Figure 3. Cellular re-distribution of C LTA  after MAD2B knockdown. (A) HEK293/T-REx cells were stably transfected with a pSUPERIOR- 
MAD2B siRNA construct (see Materials and methods). Subsequently, tetracyclin was added and cells were collected after 0, 1, 2 and 4 days, lysed and 
subjected to western blot analysis using anti-MAD2B and anti-y-tubulin (control) antibodies. (B) HEK293/T-REx/pSUPERIOR-MAD2B cells were grown 
with or w ithout tetracyclin (+/— MAD2B siRNA, respectively). Endogenous CLTA proteins were detected using an anti-CLTA antibody (green). DAPI 
staining (blue) was used to mark nuclei and chromosomes. In the presence of MAD2B CLTA localizes to mitotic spindles during mitosis, whereas after 
MAD2B depletion CLTA is re-distributed throughout the cell. 
doi:10.1371/journal.pone.0015128.g003
as centrophillic chromosomes, and destabilized kinetochore fibers. 
These defects were found to result in prolongation of mitosis due to 
continued signaling of the mitotic spindle checkpoint, presumably 
through MAD2 [5]. Since the N-terminal domain of CLTC binds 
to the spindle, it has been suggested that clathrin may act as a bridge 
between two or three microtubules within a spindle fiber to increase 
its stability [5].
MAD2B is, like its closely related homolog MAD2, a member of 
the MAD family of proteins [1,2]. Whereas the role of MAD2 in 
mitotic spindle checkpoint control is well-documented, the exact 
role of MAD2B still remains to be established. We found that 
MAD2B physically interacts and co-localizes with CLTA at the 
mitotic spindle and that depletion of MAD2B from the cells leads 
to a redistribution of CLTA and a concomitant occurrence of
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Figure 4. MAD2B depletion leads to mitotic defects. HEK293/T-REx/pSUPERIOR-MAD2B cells were transiently transfected with a H2B-RFP 
construct (see Materials and methods) and grown with or w ithout tetracyclin (+/— MAD2B siRNA), respectively. Subsequently, m itotic cells were 
scored for misaligned chromosomes. Percentages of cells with misalignments, such as centrophilic chromosomes, anaphase bridges and lagging 
chromosomes, are shown in the histogram. Black bars represent cells normally expressing MAD2B (- MAD2B siRNA; see Fig. 3, t = 0), and white bars 
represent MAD2B depleted cells (+MAD2B siRNA; see Fig. 3, t = 4). In the lower panels examples o f centrophilic chromosomes, anaphase bridges and 
lagging chromosomes are shown (arrows). 
doi:10.1371/journal.pone.0015128.g004
mitotic defects. In addition, we found that upon MAD2B 
depletion the localization of CLTC to the mitotic spindle was 
unaffected. This latter observation is completely in line with data 
indicating that the determinant for spindle binding is contained 
within the heavy chain [5]. Based on our observations and those 
reported by others, we conclude that the MAD2B-CLTA 
interaction may be functional and, as such, may play a role in 
the control of an orderly mitotic progression. Whether a functional 
loss of this interaction induces destabilization of kinetochore fibres 
and a concomitant continued signalling of the mitotic spindle 
checkpoint still remains to be established.
Clathrin has been considered to be a ‘moonlighting protein’ 
which acts during interphase in membrane trafficking and during 
mitosis in stabilizing spindle fibers [9]. Other examples of such 
proteins include NUP107, NUP133 [26], NUP358 [27] and 
RANGAP1 [28]. These proteins are involved in nuclear transport 
during interphase and localize to kinetochores on the mitotic 
spindle during mitosis to ensure orderly mitotic progression [27]. 
Until recently, it was unclear which molecule(s) might recruit 
clathrin to the mitotic spindle. Yamauchi et al. [29]. reported that 
a B-MYB complex may ferry clathrin to the mitotic spindle Our 
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Figure 5. PRCCTFE3 expression leads to mitotic defects. HEK293/T-REx/PRCCTFE3 cells were transiently transfected with a H2B-RFP construct 
(see Materials and methods) and grown with or w ithout tetracyclin (+/— PRCCTFE3), respectively. Subsequently, mitotic cells were scored for 
misaligned chromosomes. Percentages o f cells w ith misalignments, such as centrophilic chromosomes, anaphase bridges and lagging chromosomes, 
are shown in the histogram. Black bars represent un-induced cells (- PRCCTFE3), and white bars represent induced cells (+PRCCTFE3). In the right 
panel, PRCCTFE3 protein expression in the induced (+ tetracyclin) cells is shown. 
doi:10.1371/journal.pone.0015128.g005
PLoS ONE | www.plosone.org November 2010 | Volume 5 | Issue 11 | e151286
MAD2B Interacts with Clathrin Light Chain A
chain CLTA to the mitotic spindle. In t(X;1)(p11;q21)-positive 
renal cell carcinomas expressing a PRCCTFE3 fusion protein this 
function may be abrogated through an impairment of the PRCC- 
MAD2B interaction and a concomitant failure to shuttle MAD2B 
to the nucleus [15]. Accordingly, our preliminary data show that 
exogenous expression of PRCCTFE3 has a deleterious effect on 
orderly mitotic progression reminiscent of that observed after 
siRNA enforced MAD2B depletion. Teleologically, this anomaly 
may contribute to tumor development analogous to what has been 
suggested for CLTC fusions with ALK in inflammatory myofi- 
broblastic tumors and anaplastic large-cell lymphomas [10], and 
with TFE3 in renal cell carcinomas [11,12]. Also these latter 
fusions are thought to disrupt clathrin trimerization, thereby 
impairing its function during mitosis [5].
M aterials and M ethods
Yeast two-hybrid assays
Yeast two-hybrid assays were performed essentially as described 
before using a hybriZAP human testis cDNA library containing 
approximately 4x106 independent cDNA clones with an average 
insert size of ~  1 kb [15,30]. Of these, 1 x 106 clones were amplified 
once and 1 x 109 of the resulting plaque forming units were mass- 
excised according to the manufacturer’s instructions to generate an 
interaction cDNA library in pAD-GAL4. The yeast strain used for 
the interaction assays was pJ69-4A (a kind gift from Philip James). 
Positive interactions in this yeast strain can be selected for by 
adenine and histidine auxotrophy, next to b-galactosidase activity. 
The pJ69-4A strain was co-transfected with bait plasmid pBDT3C, 
carrying the human MAD2B coding sequence (AL031731), and the 
testis cDNA library using the Yeastmaker transformation kit 
(Clonetech). To select double transfectants, containing a pBD and 
a pAD vector, the transfected yeast cells were plated on synthetic 
defined (SD) medium lacking leucine and tryptophan (-LW). All 
resulting colonies were recovered from these plates, titrated, and re­
plated on SD medium lacking histidine, adenine, leucine and 
tryptophane (-HALW) to reselect yeast clones expressing MAD2B 
interacting proteins. Colonies were allowed to grow for at least 5 
days at 30°C after which replicate filters were lifted and tested for b- 
galactosidase activity according to the manufacturer’s instructions 
(LacZ filter lift assay; Stratagene). The cDNA inserts of positive 
clones were isolated by direct PCR on yeast colonies with two pAD- 
GAL4 specific oligonucleotides, pAD-for (CTGTCACCTGGTT- 
GGACGGACCAA) and pGAD-rev (GT GAACTTGCGGGGTT- 
TTTCAG). All resulting PCR products were sequenced using the 
same oligonucleotides, and the pAD plasmids of these yeast clones 
were rescued in DH5a bacteria. Finally, the interacting cDNA 
clones were retransformed together with control plasmids as 
reported before [30]. Interactions were quantified by both a liquid 
b-galactosidase assay, using o-nitrophenyl-b-D-galactopyranoside 
(ONPG) as a substrate [31], and a liquid growth assay. To this end, 
pJ69-4A yeast cells were co-transfected with pAD plasmids carrying 
different CLTA (deletion) constructs (Fig. 1A) and the MAD2B bait 
plasmid. These co-transfectants were plated on SD-LW plates and 
incubated at 30°C for 3 days, after which three independent 
colonies were picked and grown to a stationary state in 5 ml of SD- 
LW medium (2 days at 30°C). O f these cultures, 15 ml was used to 
inoculate 15 ml of SD-HLW medium. During subsequent growth at 
30°C the OD600 was monitored and, at the mid-log phase, the 
mmax was determined: mmax= [ln(xt) -  ln(x0)]/t, where xt is the 
OD600 of the culture at t = t, x0 is the OD600 at t = 0 and t is the 
time between x0 and xt. The interaction scores for each CLTA 
deletion construct were expressed as means of three independent 
clones.
Cloning and sequencing procedures
All cloning procedures were essentially as described before 
[17,30,32]. Sequence analyses were performed at the DNA 
sequence facility of the Radboud University Nijmegen Medical 
Center using a 3730 DNA Analyzer (Applied Biosystems). DNA and 
protein databases were searched using the BLAST or BLAT search 
algorithms at the NCBI or UCSC, respectively. Deletion constructs 
of human CLTA were generated by using 27-28 nt primers 
dispersed at intervals of 150 nt throughout the cDNA sequence. 
The 5 '-end of the forward primers used were located at amino acid 
positions 1, 51, 101 and 151, respectively, according to BC_009201. 
The reverse primers were located at positions 218, 167 and 117. 
Deletion constructs of human MAD2B were generated using 
primers dispersed at intervals of 150 nt throughout the cDNA 
sequence as reported before [17]. The resulting PCR products were 
cloned into pGEM-T (Promega), sequence-verified, and subcloned 
into the correct pBDT3C and pGADT3C vectors.
Cell culture
U2OS cells were cultured in DMEM (Invitrogen) supplemented 
with 10% FCS, penicillin (100 U/ml) and streptomycin (100 mg/ 
ml) at 37°C and 7.5% CO2. HEK293/T-REx cells were cultured in 
DMEM supplemented with blasticidin (5 mg/ml), penicillin 
(100 U/ml) and streptomycin (100 mg/ml). HEK293/T-REx/ 
PRCCTFE3 cells [15] were cultured in DMEM, supplemented 
with 10% FCS, zeocin (500 mg/ml), blasticidin (5 mg/ml), penicillin 
(100 units/ml) and streptomycin (100 mg/ml). For induction of 
PRCCTFE3 expression, tetracyclin was added to the culture 
medium (24 hours; 1 mg/ml). For the cellular localization studies, 
full length MAD2B was cloned into pDEST733 (mRFP; Invitrogen) 
and CLTA was cloned into pEGFP-N2 and pEGFP-C3 (Clontech). 
Cells were transiently transfected using an Amaxa Nucleofector 
according to the instructions of the manufacturer (Lonza). For 
localization of the proteins, cells were fixed one day after 
transfection for 30 min at room temperature with PBS containing 
3.7% paraformaldehyde pH 7.4 and, subsequently, embedded in 
Vectashield with DAPI (Vector Labs). Cells were then analyzed by 
immunofluorescence and/or confocal laser scanning microscopy as 
reported before [30]. For live cell imaging, cells were transiently 
transfected with a histone 2B containing pTSIN- H2B-RFP 
construct (a kind gift from Jan van Deursen) and scored for 
chromosome misalignments during mitosis using a Zeiss Axiovert 
200 M microscope. Cells were synchronized using a double 
thymidine block (early S-phase block). To this end, cells were 
incubated in DMEM supplemented with thymidine (2 mM) for
16 h, washed three times, incubated in complete DMEM without 
thymidine and grown for another 8 h prior to a second incubation 
with thymidine (2 mM) for 16 h. After release from this second 
block, cells were grown in complete DMEM during several time 
intervals. During these time intervals, cell cycle stages were 
determined by FACS analysis as reported before [17,32,33]. For 
35S methionine labelling, cells were incubated for 30 min in DMEM 
minus methionine (Invitrogen) supplemented with 10% FCS, 
penicillin (100 U/ml) and streptomycin (100 mg/ml) at 37°C and 
7.5% CO2, followed by removal ofthe medium and adding DMEM 
minus methionine supplemented with 10% FCS, penicillin (100 U / 
ml), streptomycin (100 mg/ml) and 0.25 mCi 35S methionine. Cells 
were incubated for 16 h at 37°C and 7.5% CO2 before harvesting.
GST pull-down and co-immunoprecipitation assays
The full length CLTA coding sequence was cloned into a 
pDEST15 vector (Invitrogen) and transformed into BL21-DE3 
cells (Promega), yielding a fusion protein with a GST tag at the N- 
terminus (GST-CLTA). Purification of this fusion protein was
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performed as described by Kantardzhieva et al. [34]. The full 
length MAD2B coding sequence was cloned into a pDEST303 
vector, yielding a HA-tagged MAD2B protein (HA-MAD2B) and 
transfected into U2OS cells after sequence verification. For the 
GST pull-down assays, 50 ml of GST-CLTA was combined with 
100 ml of lysates from U2OS cells expressing HA-MAD2B. In 
addition, 50 ml glutathione Sepharose 4B slurry (Amersham 
Biosciences) was used. A protease inhibitor cocktail (Roche) was 
added during all wash steps. Before use, the sepharose beads were 
washed twice with TBS (25 mM Tris pH 7.4 and 150 mM NaCl), 
followed by a 2 h incubation of the GST-CLTA (and GST alone 
as a control) with the beads. After this incubation, the GST- 
coupled beads were washed with TBSTD buffer (25 mM Tris 
pH 7.4, 150 mM NaCl, 1.0% Triton X-100 and 2 mM DTT), 
and incubated overnight at 4°C with lysates of U2OS cells 
expressing HA-MAD2B (see above). After five additional washes 
with lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl and 
0.5% Triton X-100) and washing buffer (50 mM Tris-HCl 
pH 7.5, 100 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 1% Triton 
X-100 and 2 mM DTT) the samples were denatured and loaded 
onto 4-12% NuPAGE polyacrylamide gels (Invitrogen). After 
electrophoreses the gels were blotted onto nitrocellulose mem­
branes (Protran, Schleicher and Schuell). The resulting blots were 
blocked in PBS with 5% non fat dry milk and incubated with anti- 
MAD2B antibody for 1 h at room temperature and, subsequently, 
with either a peroxidase conjugated secondary antibody (Zymed) 
or a fluorescent conjugated secondary antibody (Molecular 
Probes). Peroxidase signals were visualized using auto-radiograph­
ic exposure to Kodak X-Omat films, while fluorescent signals were 
scanned and analyzed with the Odyssey system and its associated 
software (Li-Cor). For immunoprecipitation studies, the full length 
CLTA coding sequence was cloned into a pDEST306 vector, 
yielding a FLAG-tagged CLTA protein (FLAG-CLTA) and 
transfected into U2OS cells after sequence verification. Cells were 
washed three times in ice-cold PBS and scraped from the tissue 
culture dishes. Total cell lysates were prepared in 1 ml lysis buffer 
(PBS,10% glycerol, 0.1% NP40, protease inhibitors), kept on ice 
for 10 min while vortexed gently at 2 min intervals, and 
centrifuged for 30 min at 38.500 rpm at 4°C. The supernatants 
were pre-cleared in 100 ml of protein A /G  PLUS Sepharose (50% 
slurry in lysis buffer; Santa Cruz) for 1 h at 4°C and subsequently 
centrifuged for 3 min at 2500 rpm at 4°C. Immunoprecipitations 
were performed with these pre-cleared supernatants by adding 1­
5 mg primary antibody, followed by a 1 h rotation at 4°C. 
Subsequently, 25 ml protein A /G  PLUS Sepharose (50% slurry in 
lysis buffer; Santa Cruz) was added to the immune complexes for
1 h at 4°C. The sepharose-bound immune complexes were 
collected by centrifugation (3 min; 2500 rpm; 4°C) and the 
resulting pellets were washed five times with lysis buffer before 
antigens were released by heating at 95°C for 5 min. Western 
blotting was performed as described above. For quantification of 
western blot signals the ImageJ software tool was used (h ttp ://rsb . 
info.nih.gov/ij/). The area under the curve (AUC) of a specific 
signal was corrected by the AUC of the loading control. The 
measurements of uninduced samples were arbitrarily set at 100% 
and the other conditions were recalculated correspondingly, 
thereby allowing ratio comparisons.
RNA interference assays
MAD2B-specific siRNA constructs were generated in a 
pSUPERIOR vector (OligoEngine). To this end, the following 
primers were used: forward GATCCCCCTGTGAGTTGTTT- 
CAATAAttcaagagaTTA-TTGAAACAACTCACAGTTTTTGG- 
AAA and reverse AGCTTTTCCAAAAACTGTGAGTTGTTT-
CAATA-AtctcttgaaTTATTGAAACAACTCACAGGGG. The 
forward and reverse strands of oligo’s containing the MAD2B 
siRNA-expressing sequence were annealed and subsequently 
cloned into pSUPERIOR. Two days after transfection of this 
construct into HEK293/T-REx cells, transfected cells were 
selected using 2 mg/ml puromycin (Sigma Aldrich), expanded 
and tested for MAD2B expression after tetracyclin induction.
Antibodies
A polyclonal rabbit anti-MAD2B antibody was used as 
described before [15]. Monoclonal mouse anti-FLAG (Sigma), 
monoclonal mouse anti-HA (Sigma), monoclonal mouse anti-y- 
tubulin (Abcam), polyclonal rabbit anti-a-tubulin (Santa Cruz), 
monoclonal mouse anti-CLTA (Sigma), polyclonal rabbit anti- 
CLTA (Protein Tech Group) and monoclonal mouse anti-CLTC 
(alias CHC; Abcam) antibodies were used according to the 
instructions of the manufacturers.
Supporting Inform ation
Figure S1 Synchronization o f  U2OS cells and cell cycle 
distribution. U2OS cells were synchronized using a double 
thymidine block (early S-phase block; see Materials and Methods) 
and subsequently released during several time intervals (t = 0 to 
t=  15 h). Concurrent cell cycle distributions were measured using 
FACS analysis and expressed as percentages G0/G1, S and G 2/ 
M cells, respectively [31;32].
(PDF)
Figure S2 CLTC localization is not affected by MAD2B 
knockdown. (A) U2OS cells were grown in the presence of 35S- 
labelled methionine. Subsequent immunoprecipitations were per­
formed on cell lysates using anti-CLTA, anti-MAD2B and control 
(IgG) antibodies. CLTC marks the position of the clathrin heavy 
chain. (B) HEK293/T-REx/pSUPERIOR-MAD2B cells were 
grown in the presence of tetracyclin (+MAD2B siRNA). Endoge­
nous CLTC proteins were detected using an anti-CLTC antibody 
(red). DAPI staining (blue) was used to mark nuclei and 
chromosomes. CLTC localizes to the mitotic spindle during mitosis 
after MAD2B depletion.
(PDF)
Figure S3 CLTA co-localizes with a-tubulin at the 
m itotic spindle. U2OS cells were stained with anti-CLTA 
(green) and anti-a-tubulin (red) antibodies. DAPI staining (blue) 
marks the position of the chromosomes. Yellow staining in the 
overlay indicates co-localization of endogenous CLTA and a- 
tubulin at the mitotic spindle.
(PDF)
Table S1 M itotic defects in HEK293/T-REx after 
MAD2B depletion. HEK293/T-REx/pSUPERIOR-MAD2B
cells were transiently transfected with a H2B-RFP construct (see 
Materials and methods) and grown with or without of tetracyclin 
(+ /— MAD2B siRNA), respectively. Subsequently, cells were live 
recorded and scored for chromosome misalignments during 
mitosis. Numbers (#) and percentages (%) of cells with 
misalignments, such as centrophilic chromosomes, anaphase 
bridges and lagging chromosomes are listed.
(DOC)
Table S2 M itotic defects in HEK293/T-REx after 
PRCCTFE3 induction. HEK293/T-REx/PRCCTFE3 cells 
were transiently transfected with a H2B-RFP construct (see 
Materials and methods) and grown with or without of tetracyclin
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(+ /— PRCCTFE3), respectively. Subsequently, cells were live 
recorded and scored for chromosome misalignments during 
mitosis. Numbers (#) and percentages (%) of cells with 
misalignments, such as centrophilic chromosomes, anaphase 
bridges and lagging chromosomes are listed.
(DOC)
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